The evaluation of the possibility of the estimation the amount of hemagglutininin in the final lots of inactivated adjuvanted influenza vaccines
- 作者: Butirskiy A.Y.1, Morozova E.N.1, Sarkisyan K.A.1
-
隶属关系:
- Scientific Center for Expert Evaluation of Medicinal Products
- 期: 卷 70, 编号 1 (2025)
- 页面: 57-65
- 栏目: ORIGINAL RESEARCH
- URL: https://ogarev-online.ru/0507-4088/article/view/287910
- DOI: https://doi.org/10.36233/0507-4088-286
- EDN: https://elibrary.ru/itvlmz
- ID: 287910
如何引用文章
详细
Introduction. The main quality indicator for inactivated influenza vaccines is their potency (the amount of hemagglutinin). The potency test for the influenza vaccine with the SOVIDON adjuvant is carried out in a trivalent bulk vaccine before the addition of the adjuvant. This approach has its fair share of drawbacks. The analysis of the statistical process control and stability by control charts plays an important role in the release of influenza vaccines.
The aim of the study is to compare the results of hemagglutinin quanitation in the trivalent bulk vaccine and in the final lots of influenza vaccine with SOVIDON adjuvant; as well as the analysis of the potency test results to evaluate the statistical process control.
Materials and methods. This study covered the inactivated influenza vaccine with the SOVIDON adjuvant. Both the trivalent bulks vaccine before the addition of the adjuvant and the final lots were investigated by single radial immunodiffusion assay. The software SIAMS Photolab was used to calculate the amount of hemagglutinin. Microsoft Excel was used to create the control charts using the data of the manufacturer.
Results. The data of the study confirm the absence of statistically significant differences (p < 0.05) of the content of hemagglutinin in the trivalent bulks and the final lots of the influenza vaccine. The analysis of control charts showed the presence of out-of-control signals.
Conclusion. The study has shown the possibility and feasibility of the potency testing of the influenza vaccine with the SOVIDON adjuvant. The presence of out-of-control signals on the control charts is the basis for the identification of the reasons behind the changes and for the analysis of risks of the release of a defective influenza vaccine.
作者简介
Aleksey Butirskiy
Scientific Center for Expert Evaluation of Medicinal Products
编辑信件的主要联系方式.
Email: butirskiy@expmed.ru
ORCID iD: 0000-0002-0352-522X
chief expert of viral vaccines laboratory
俄罗斯联邦, 127051, MoscowElena Morozova
Scientific Center for Expert Evaluation of Medicinal Products
Email: Morozovaen@expmed.ru
ORCID iD: 0009-0005-0478-1558
expert of viral vaccines laboratory
俄罗斯联邦, 127051, MoscowKarine Sarkisyan
Scientific Center for Expert Evaluation of Medicinal Products
Email: Sarkisyan@expmed.ru
ORCID iD: 0000-0003-0445-7086
candidate of medical science, head of viral vaccines laboratory
俄罗斯联邦, 127051, Moscow参考
- Nikiforov V.V., Polibin R.V., Suranova T.G., Polezhaeva N.A. Flu yesterday, today and tomorrow. The results of monitoring immunization and morbidity in the epidemic seasons 2019–2020, 2020–2021, 2021–2022, 2022–2023. Epidemiologiya i infektsionnye bolezni. 2023; 28(6): 373–86. https://doi.org/10.17816/EID607411 https://elibrary.ru/milthb (in Russian)
- Erofeeva M.K., Stukova M.A., Shakhlanskaya E.V., Buzitskaya Zh.V., Maksakova V.L., Krainova T.I. et al. Evaluation of the preventive effectiveness of influenza vaccines in the epidemic season 2019–2020 in St. Petersburg. Epidemiologiya i vaktsinoprofilaktika. 2021; 20(5): 52–60. https://doi.org/10.31631/2073-3046-2021-20-5-52-60-52-60 https://elibrary.ru/zcbuzk (in Russian)
- Wood JM, Schild GC, Newman RW, Seagroatt V. An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines. J Biol Stand. 1977; 5: 237-247. https://doi.org/10.1016/S0092-1157(77)80008-5.
- John M.Wood, Jerry P.Weir. Standardisation of inactivated influenza vaccines – Learning from history. Influenza Other Respi Viruses. 2018; 12: 195-201. doi: 10.1111/irv.12543. Epub 2018 Feb 2.
- Nikiforova A.N., Isakova-Sivak I.N., Erofeeva M.K., Fel’dblum I.V., Rudenko L.G. The results of studying the Safety and immunogenicity of domestic subunit adjuvanted vaccine Sovigripp in volunteers from 18 to 60 years old. Epidemiologiya i vaktsinoprofilaktika. 2014; (2): 72–8. https://elibrary.ru/sbeunx (in Russian)
- Philip D. Minor. Assaying the Potency of Influenza Vaccines. Vaccines. 2015; 3(1): 90-104. https://doi.org/10.3390/vaccines3010090.
- Khokhlov A.L., Pyatigorskaya N.V., eds. The Industrial Pharmacy. Product Development Cycle [Promyshlennaya farmatsiya. Put’ sozdaniya produkta]. Moscow: Rossiiskaya akademiya nauk; 2019. (in Russian)
- Demidova P.V., Mefed K.M., Davydov D.S., Sarkisyan K.A., Movsesyants A.A., Merkulov V.A. Analysis of batch to batch consistency of a locally produced influenza vaccine for the 2017–2018 influenza season. BIOpreparaty. Profilaktika, diagnostika, lechenie. 2018; 18(2): 121–32. https://doi.org/10.30895/2221-996X-2018-18-2-121-132 https://elibrary.ru/xqrelj (in Russian)
- Alekseeva I.A., Perelygina O.V., Kolyshkina E.D. Estimation of production consistency of diphtheria, tetanus, and pertussis components of the DTP vaccine using Shewhart charts. BIOpreparaty. Profilaktika, diagnostika, lechenie. 2021; 21(4): 256–65. https://doi.org/10.30895/2221-996X-2021-21-4-256-265 https://elibrary.ru/vnsstr (In Russian)
- Wheeler D., Chambers D. Understanding Statistical Process Control. Knoxville, Tennessee: SPC Press; 1992.
补充文件
